- Filed
- Jun 14, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Jun 14, 2023 | 165.19M sh |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $74.52K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $21.14K |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $765.51K |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $273.65K |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $1.1M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $868.34K |
| Current Assets | Q3 2021 · Sep 30, 2021 | $242.94K |
| Current Assets | Q3 2021 · Dec 31, 2020 | $99.98K |
| Total Assets | Q3 2021 · Sep 30, 2021 | $242.94K |
| Total Assets | Q3 2021 · Dec 31, 2020 | $99.98K |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 165.19M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 165.19M sh |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | $18.06K |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | −$725.86K |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | −$707.92K |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | −$648.26K |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$676.69K |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.00 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.00 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.00 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.00 |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $75.94K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $252.25K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$17.94K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$49.17K |
| Net Income | Q3 2021 · Jun 30, 2020 | −$59.67K |
| Net Income | Q3 2021 · Mar 31, 2020 | $28.44K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$13.64K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$37.31K |
| Revenue | Q3 2021 · Sep 30, 2020 | $62.3K |
| Revenue | Q3 2021 · Sep 30, 2020 | $214.94K |